Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02825771 · ClinicalTrials.gov registry record · NA
Caring Contacts: A Strength-based, Suicide Prevention Trial in 4 Native Communities
A NA study of Suicidal Ideation and Suicide, Attempted, sponsored by Washington State University.
- Active
- Registry status
- NA
- Development phase
- 711
- Enrollment target
- 1
- Study location
NCT02825771: Active NA study of Suicidal Ideation and Suicide, Attempted, sponsored by Washington State University.
NCT02825771 is a NA study of Suicidal Ideation and Suicide, Attempted that is active but no longer recruiting, run by Washington State University. The registered enrollment target is 711 participants, above the 259-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (175% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02825771, a NA study of Suicidal Ideation and Suicide, Attempted, is active but no longer recruiting, sponsored by Washington State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 711 participants
- Enrollment target
- 1
- Study location
Study Summary
Suicide is the second leading cause of death for American Indians and Alaska Natives aged 18 years and older. This study will evaluate Caring Contacts, a low-cost, sustainable intervention for suicide prevention that sends caring messages to people at risk. The investigators will implement the intervention at four tribal sites, leveraging community strengths and values to address this tragic health disparity in an underserved minority population.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Caring Contacts Messages
Study Locations (1)
Washington
- Washington State University - Spokane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 711 participants |
| Start Date | 2018-05-30 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
What the registry record for NCT02825771 still lists
NCT02825771 is an interventional study that assigns participants to a tested intervention. The registered 711 participants enrollment target is mid-sized for trials with a published cap, above the 259-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (175% higher).
The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT02825771 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT02825771 about?
NCT02825771 is a clinical study titled "Caring Contacts: A Strength-based, Suicide Prevention Trial in 4 Native Communities". Suicide is the second leading cause of death for American Indians and Alaska Natives aged 18 years and older. This study will evaluate Caring Contacts, a low-cost, sustainable intervention for suicide prevention that sends caring messages to people at risk. The investigators will implement the inter...
What is the current status of trial NCT02825771?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 711 participants. The study started on 2018-05-30. Estimated completion is 2025-10-31.
What conditions does trial NCT02825771 study?
This clinical trial studies the following conditions: Suicidal Ideation, Suicide, Attempted.
What interventions are being tested in trial NCT02825771?
The interventions under investigation include: Usual Care (BEHAVIORAL), Caring Contacts Messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT02825771?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02825771 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02825771's enrollment target sits among peer trials
711 8th of 84 higher than 77 of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06179160 · 710 participants · Phase 1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- NCT06235697 · 710 participants · Phase 3
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- NCT06470867 · 710 participants · NA
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
- NCT07022483 · 710 participants · Phase 3
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI